Literature DB >> 19577623

Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells.

Ji Young Park1, Hwa Kyoung Shin, Young Whan Choi, You Jin Lee, Sun Sik Bae, Jin Han, Chi Dae Kim.   

Abstract

AIM OF THE STUDY: Gomisin A (GA) is a small molecular weight lignan contained in Fructus Schisandrae, the dried seed of Schisandra chinensis which is widely used as a tonic in traditional Korean medicine. We previously demonstrated that GA induces endothelium-dependent and -independent relaxation in rat thoracic aorta, however the signaling pathways involved was not clarified. In this study, we examined whether GA could actually induce nitric oxide (NO) production and clarified the mechanism in cultured human coronary artery endothelial cells (HCAEC).
RESULTS: Treatment of HCAEC with GA induced NO production in a time- and concentration-dependent manner in association with an enhanced endothelial NO synthase (eNOS) activity with an increased cytosolic translocation of eNOS. Both GA-induced NO production and eNOS activation were attenuated by pretreatment of the cells with EGTA, an extracellular Ca(2+) chelator, and BAPTA-AM, an intracellular Ca(2+) chelator, but not by LY 294002, a PI3-kinase/Akt inhibitor, suggesting involvement of Ca(2+). Furthermore, GA rapidly increased the intracellular Ca(2+) concentration, which was abolished in Ca(2+) free media.
CONCLUSION: Taken together, our results suggest that GA induces Ca(2+)-dependent activation and translocation of eNOS in HCAEC, events linked to NO production and thereby endothelial-dependent vasorelaxation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577623     DOI: 10.1016/j.jep.2009.06.028

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Effects of gomisin A on vascular contraction in rat aortic rings.

Authors:  Young Mi Seok; Young Whan Choi; Gyung-Duck Kim; Hye Young Kim; Yoh Takuwa; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

2.  Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.

Authors:  Byeong Hyeok Ye; Seung Jin Lee; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

3.  Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.

Authors:  Ji Young Park; Jung Wook Yun; Young Whan Choi; Jin Ung Bae; Kyo Won Seo; Seung Jin Lee; So Youn Park; Ki Whan Hong; Chi Dae Kim
Journal:  Hypertens Res       Date:  2012-04-26       Impact factor: 3.872

Review 4.  Vasodilator compounds derived from plants and their mechanisms of action.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; Alejandra Rojas-Molina; Isela Rojas-Molina; Miguel Angel Zavala-Sánchez
Journal:  Molecules       Date:  2013-05-17       Impact factor: 4.411

Review 5.  Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

Authors:  Anzhu Wang; Wei Zhao; Kaituo Yan; Pingping Huang; Hongwei Zhang; Zhibo Zhang; Dawu Zhang; Xiaochang Ma
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

6.  Antiasthmatic effects of schizandrae fructus extract in mice with asthma.

Authors:  Hyungwoo Kim; Yong-Tae Ahn; Youn Sook Kim; Su In Cho; Won Gun An
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

7.  Atractylodin Induces Myosin Light Chain Phosphorylation and Promotes Gastric Emptying through Ghrelin Receptor.

Authors:  Yu Bai; Yan-Hua Zhao; Jian-Ya Xu; Xi-Zhong Yu; Yun-Xia Hu; Zhi-Qiang Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-13       Impact factor: 2.629

Review 8.  Secondary Metabolites of Plants as Modulators of Endothelium Functions.

Authors:  Anna Bartáková; Marie Nováková
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.